Drugs with this side effect
- 2-hydroxysuccinaldehyde: 10%
- 5-ASA: postmarketing
- 5-FU
- 5-aza-2'-deoxycytidine: 6.17% - 12%
- 5-azacytidine: common, 0% - 7.73%
- 6-mercaptopurine
- 6-thioguanine
- BCNU: 1-10%
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- FAMP: 0% - 9%
- FdUrd
- Glat copolymer: infrequent
- K779
- L-Dmp: rare
- LY146032
- N-acetylcysteine
- PCI-32765: 1% - 17%
- Romidepsin: 0% - 9.92%
- SU5416
- Sativex
- abacavir
- acitretin: postmarketing
- actinomycin D: 30%
- afatinib: very common, 0% - 71%
- alendronate
- allopurinol: postmarketing
- amitriptyline
- amoxapine: postmarketing
- amoxicillin
- amphotericin B
- ampicillin
- amsacrine
- anthracycline: 0% - 9%
- aprepitant: 4.4% - 5.3%
- aripiprazole
- arsenic
- articaine
- atorvastatin
- auranofin: postmarketing, 13% - 18%
- axitinib: 1% - 15%
- azithromycin
- balsalazide: 0% - 5.71%
- bendamustine
- bexarotene
- bleomycin hydrochloride: 30%
- boceprevir: postmarketing, common
- bortezomib: 1%
- bupropion: postmarketing, infrequent, frequent
- busulfan: 85% - 97%
- cabozantinib: 0% - 51%
- capecitabine: 1% - 62%
- captopril
- carbamazepine: very rare
- carboplatin
- cefdinir: postmarketing
- cefditoren
- cefpodoxime
- ceftriaxone: postmarketing, 0.1%
- celecoxib
- cetirizine
- cevimeline
- chloramphenicol
- chlorhexidine
- chlorhexidine gluconate
- cidofovir
- ciprofloxacin
- cisplatin
- citalopram: postmarketing, rare, infrequent, uncommon
- clarithromycin: postmarketing, uncommon
- clofarabine: common
- clopidogrel: postmarketing
- colchicine
- copolymer 1
- cyclobenzaprine: postmarketing
- cyclophosphamide: postmarketing
- dabrafenib
- dacarbazine
- darunavir
- dasatinib
- delavirdine
- deprenyl: 5%
- desipramine
- dexrazoxane: 26% - 36%
- diclofenac: very rare
- dicloxacillin
- diflunisal
- docetaxel: 0% - 68%
- dolasetron
- domperidone
- dothiepin
- doxepin
- doxorubicin: postmarketing, uncommon, common, very common, 0% - 41.4%
- doxycycline
- duloxetine: postmarketing, infrequent, uncommon
- eletriptan: rare
- eribulin
- erlotinib: 0% - 17%
- ertapenem
- esomeprazole magnesium: postmarketing
- ethionamide
- etodolac
- etoposide: 1 to 6 - 1-6%
- etoposide phosphate
- etravirine
- everolimus: common, very common, 0% - 78%
- fentanyl: 0% - 8.33%
- fluconazole
- fludarabine: 0% - 9%
- fluoxetine: infrequent
- flurbiprofen
- fluvoxamine: rare, infrequent
- fosaprepitant
- fosaprepitant dimeglumine
- frovatriptan: rare
- gabapentin: rare, infrequent
- gatifloxacin
- gefitinib: 0% - 8%
- gemcitabine: common, 0% - 66%
- gemifloxacin
- gentamicin
- gold sodium thiomalate
- halofantrine
- histamine
- hydromorphone
- hydroxybutyrate
- hydroxyurea: 1-5%
- ibandronate: postmarketing
- ibuprofen
- idarubicin
- ifosfamide: 1%
- iloperidone
- imatinib: uncommon, 0.6% - 16.3%
- imipramine: very rare
- indapamide
- indomethacin
- ipratropium bromide: postmarketing, uncommon
- irinotecan: 0.7% - 12%
- ixabepilone: 4% - 29%
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- lamivudine: postmarketing, 6% - 12%
- lamotrigine: rare, infrequent, 1%
- lansoprazole
- lapatinib: very common, 0% - 11%
- leflunomide
- lenalidomide: postmarketing
- lercanidipine: rare
- letrozole: uncommon
- leucovorin: 16% - 84%
- lidocaine
- lincomycin
- linezolid
- lomefloxacin
- lomustine
- lymecycline
- mTHPC
- mannitol
- maprotiline
- maraviroc: 2.6%
- meclofenamate
- mefenamic acid
- meloxicam
- melphalan: rare
- meprobamate
- methotrexate
- metronidazole
- midodrine
- minocycline: 6.4% - 9.2%
- mirtazapine: postmarketing, infrequent
- mitomycin C
- mitoxantrone: 8% - 33%
- moclobemide
- morphine
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- nabumetone: 0.4%
- nafcillin
- naproxen: postmarketing
- nefazodone: infrequent
- nelarabine: 0% - 8%
- niacin
- nicorandil: rare
- nicotine
- nilotinib: uncommon
- nitroglycerin
- norfloxacin: postmarketing
- nortriptyline
- ofloxacin
- olanzapine: infrequent
- olsalazine: 1%
- omeprazole: postmarketing, rare
- oxacillin
- oxaliplatin: very common, 0% - 61.6%
- oxaprozin
- oxcarbazepine
- oxybutynin
- oxycodone
- paclitaxel
- pamidronate: 0% - 3%
- pantoprazole
- paroxetine: rare, common
- pazopanib: 0% - 11%
- pemetrexed: 0% - 28%
- penicillin
- pentostatin: 5% - 12%
- perindopril erbumine
- pilocarpine
- piperacillin: uncommon
- pirbuterol
- piroxicam: 1%
- pixantrone
- ponatinib
- posaconazole
- pregabalin: infrequent
- procarbazine
- proguanil
- protriptyline
- quetiapine: infrequent
- rabeprazole
- raltitrexed: 9%
- ramipril
- rapamycin: postmarketing, common
- rasagiline: infrequent
- regorafenib
- retinoic acid
- ribavirin: common
- riluzole: 0.8% - 1.2%
- rimantadine
- risperidone: infrequent
- ritonavir
- ropinirole: infrequent
- salbutamol: postmarketing
- saquinavir
- sertraline: rare
- sibutramine
- sildenafil
- sitaxsentan
- sodium cromoglycate
- sorafenib: postmarketing, common, 0% - 11%
- sparfloxacin
- strontium ranelate: postmarketing
- sulfadiazine
- sulfamethoxazole
- sulfasalazine: 4%
- sulindac
- sunitinib
- tacrolimus: common
- telithromycin
- temozolomide: common, 0% - 9%
- temsirolimus
- teniposide
- tenoxicam: common
- testosterone: postmarketing
- thalidomide
- thiotepa
- tiagabine: frequent
- tiaprofenic acid: 1.1% - 2.4%
- tinidazole
- tiotropium
- tobramycin
- tolmetin
- topiramate: infrequent
- topotecan: very common, 0% - 18%
- trabectedin
- tramadol: postmarketing
- trametinib: 0% - 15%
- triazolam
- trimethoprim: very rare
- trimethoprim-sulfamethoxazole: very rare
- trimipramine
- trovafloxacin
- v 1784: postmarketing, 5% - 7%
- valdecoxib
- valproate
- vandetanib
- venlafaxine: infrequent
- vincristine
- vinflunine
- vinorelbine: 15-16%
- voriconazole
- zaleplon: infrequent
- zidovudine: 6% - 12%
- zoledronic acid: uncommon
- zolmitriptan: rare
- zonisamide: infrequent
- zopiclone: rare
|
